Automated insulin delivery versus injections for hospital diabetes care
Part of Hormones & metabolism, Infections clinical trials.
This study compares two ways to manage blood sugar in the hospital for people with type 2 diabetes: an automated insulin delivery system (a pump worn on the body with a continuous glucose monitor) versus the usual daily insulin injections. The goal is to see if the automated system keeps blood sugar in a safer range during an acute illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to have type 2 diabetes and currently be using insulin injections (not a pump).
- You must have an active infection (like a flu or a urinary tract infection) that requires hospital care.
- Your hospital stay is expected to last at least 2 days after you join the study.
- You should not already be using an insulin pump or an automated insulin delivery system.
- You must be able to communicate with the study team and follow the plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial is testing a closed-loop system that automatically adjusts insulin delivery to keep blood sugar in a healthy range, in a simulated hospital setting. If you have type 1 or type 2 diabetes and use insulin, this could help you manage your glucose more effectively.
This trial tests whether using your own continuous glucose monitor (CGM) while you are in the hospital (but not the ICU) can help better manage your blood sugar levels. If you already use a CGM at home and are admitted for at least two days, you may be able to keep using it during your stay.
This study tests whether using a continuous glucose monitor (CGM) can help people with type 2 diabetes who need insulin after leaving the hospital. It aims to improve blood sugar control during this transition period.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
Hear when a new CGM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.